MENU
INM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

InMed Pharmaceuticals (INM) Ownership - Who owns InMed Pharmaceuticals?

InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors... Show more

Profile

Industry
N/A
Address
c/o Norton Rose Fulbright Canada LLP, 510 West Georgia Street
Phone
+1 604 669-7207
Employees
6
Web
https://www.inmedpharma.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
7.58M
P/E Ratio
-0.44
Total Cash
2.19M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
2.54
Dividend Yield
N/A
Total Cash/Share
0.40
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Who owns InMed Pharmaceuticals? INM symbol Ownership - Tickeron.com